KV1.3 belongs to the Shaker family of voltage-dependent K+ channels.
The channel is widely expressed in the brain, lung and osteoclasts and in several cell populations of hematopoietic origin. It is in these cells (particularly T lymphocytes) that Kv1.3 function has centered a lot of attention. It was found that Kv1.3 is the main channel
responsible for maintaining the resting potential in quiescent cells and regulating the
Ca2+ signaling that is indispensable for normal T lymphocyte activation.1,2
Based on the central role of KV1.3 in regulating the initiation of an immune response,
the channel has been recognized as a potential target for immunosuppressant drugs.1
KV1.3 channels are potently inhibited by several venomous peptide toxins among them
rCharybdotoxin (#RTC-325), rNoxiustoxin (#RTN-340), rKaliotoxin (#RTK-370),
rMargatoxin (#RTM-325), rAgitoxin-1 (#RTA-150), rAgitoxin-2 (#RTA-420),
rHongotoxin-1 (#RTH-400) and rStichodactyla Toxin (#RTS-400).3-7
The central role of KV1.3 in immune system cells created a real need for a specific
antibody that would be able to work in flow cytometry applications.
Alomone has now developed an anti-KV1.3 antibody directed against a specific
extracellular epitope of the channel.
The antibody can be obtained in a purified format (#APC-101) or labeled with
fluorescein (#APC-101F). The antibodies have been tested in flow cytometry,
immunocytochemistry and western blot applications.